Skip to main content
. 2023 Feb 13;28(4):1762. doi: 10.3390/molecules28041762

Table 5.

New drugs for the treatment of drug-resistant tuberculosis.

Generic Name Brand Name Company Approval CAS Number Clinical Indications Molecular Mechanism
Bedaquiline (59) Sirturo Janssen Therapeutics 2012 843663-66-1 Multidrug-resistant tuberculosis Adenosine triphosphate synthase inhibitor
Delamanid (60) Deltyba Otsuka 2014 681492-22-8 Multidrug-resistant tuberculosis Cell wall synthesis inhibitor
Pretomanid (61) Dovprela Mylan 2019 187235-37-6 Multidrug-resistant tuberculosis Cell wall synthesis inhibitor